For Life Science clusters to develop into effective ecosystems all stakeholders whether public or private have key roles to play. Recent announcements in Indiana, where Eli Lilly & Company have committed to investing $4.5Bn to expanding their R&D footprint with the creation of the Lilly Medicine Foundry due to open in 2027. This after already having announced $9Bn of investment in the region earlier in 2024. The UK has long been felt by many to be a leading Life Science cluster primed for scaling up. With the visit of David Rosenberg, Secretary of Commerce for Indiana to London, Mathys & Squire are generously hosting this traditional Genesis Fringe curtain-raiser where speakers will discuss what it takes to grow a World class Life Science ecosystem competitive in the discovery, manufacture and commercialisation of innovative medicines.

Agenda:
08.30 – Registration & Networking
09.00 – Welcome
09.10    – Enabling Development of an Ecosystem
David Rosenberg, Secretary of Commerce, Indiana
09.25 – IP Strategy in a Connected Ecosystem
Craig Titmus, Partner, Mathys & Squire
09.40 – Q&A Panel
Tony Jones, One Nucleus (moderator)
Laura Lane, Eli Lilly & Co
Alessia Errico, Cancer Research UK
David Rosenberg, Secretary of Commerce, Indiana
Craig Titmus, Mathys & Squire
10.30    – Closing Remarks
11.00 – Close

Registration:
This event is free to attend, invite only and is particularly aimed at attendees from:

•            Life Science R&D companies

•            TechBio companies

•            Tech Transfer Offices/Academia

•            Investors

•            CRO/CDMO companies

To request an invitation, please email Tony Jones directly.